International Scientific Collaboration (ISC) members work to guide new innovations in medical technology for the healthcare system by facilitating teamwork and partnerships within the global scientific community.
EXCITE International (EI) aims to develop high quality multinational studies amongst member countries according to an inclusive approach to protocol designs that:
The EI Scientific Collaboration (SC) is comprised of international experts from within the scientific community who will guide the development of protocols that will allow EI to fulfill its mandate as set out above.
The SC is advisory to the Global Methodology Resource Centre (GMRC) selected to assemble the protocol for each approved technology.
Detailed protocol development will be undertaken by the GMRC working closely with Key International Opinion Leaders (KOLs) and EI committees that express the interests of payers and patients.
The GMRC will also be responsible for ensuring input by Regulators into protocol development. The SC will provide ongoing advice to the GMRC and advice to the EI Board regarding approval or the final protocol. Terms of reference for the SC are attached as Appendix 1. Membership of the Scientific Collaboration is attached as Appendix 2.
It is important to point out that industry is expected to be very much involved in protocol development and has to sign off on the final protocol.
Naomi Aronson, PhD, is the Executive Director of Clinical Evaluation, Innovation, and Policy, Blue Cross & Blue Shield Association.
» More
Dr. Cafazzo is Lead for the Centre for Global eHealth Innovation. As a biomedical engineer, he has spent his entire career in hospitals.
» More
Brett Hauber, PhD, has more than 15 years of academic, research, and government experience in health and environmental economics.
» More
Dr. Jüni is internationally renowned for his methodological work and for his research on cardiovascular and musculoskeletal disorders.
» More
Dr. Bryan R. Luce is President & CEO of Luce Outcomes Research and Affiliate Professor, School of Pharmacy, University of Washington.
» More
Dr. Peter McCulloch is a Reader (Assistant Professor) in surgery at University of Oxford. He takes a keen interest in surgical safety and quality.
» More
Dr. Miller's work centres on health technology policy and brings a health policy perspective to analyzing systems of health research and innovation.
» More
Dr. Amit Oza is a Medical Oncologist and Professor of Medicine at University of Toronto and CEO of Ozmosis Research, a not for profit social enterprise clinical research organization.
» More
Dr. Joseph Ross is a Professor of Medicine and of Public Health at the Yale School of Medicine and a member of the Center for Outcomes Research and Evaluation at the Yale-New Haven Hospital.
» More
Rod has been working in health service research and health technology assessment for over 20 years and has published more than 200 research articles.
» More